CME Group CME BMRA Biomerica falls 047 after reporting Q1 2026 negative EPS of 044 with no available analyst consensus estimates Is Rigel Pharmaceuticals RIGL stock cheap relative to earnings growth Rigel Pharmaceuticals misses EPS estimates by 96 CHR Cheer reports 11 percent Q1 2026 revenue growth shares dip 117 percent after quarterly earnings release Lucid Group LCID Assessing the RiskReward Opportunity at Its MultiYear Price Low Chevron Corporation CVX Strategic Value and Operational Excellence Position Energy Giant for Growth in 2026 TPST Tempest Therapeutics tops Q4 2025 EPS estimates shares jump more than 14 percent in todays trading Patria Investments Limited PAX Sees Modest Gains Amid Stabilization Attempt Patagonia Trademark Lawsuit Against Drag Performer Pattie Gonia Highlights Brand Protection Challenges KMI Q1 2026 Earnings EPS Surges Past Estimates with 1928 Beat Scaling Safe Enterprise AI with OpenAI Governance Frameworks